Pelitinib Uses, Dosage, Side Effects and more
Pelitinib (EKB-569) is a potent, low molecular weight, selective, and irreversible inhibitor of epidermal growth factor receptor (EGFR) that is being developed as an anticancer agent.
| Trade Name | Pelitinib |
| Generic | Pelitinib |
| Pelitinib Other Names | Pelitinib |
| Type | |
| Formula | C24H23ClFN5O2 |
| Weight | Average: 467.93 Monoisotopic: 467.1524309 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Investigated for use/treatment in colorectal cancer and lung cancer.
